Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of MicroMatrix® Flex in Wounds Complicated by Tunneling and Undermining

NCT06629506 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT06629506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06629506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of MicroMatrix® Flex in Wounds Complicated by Tunneling and Undermining
Lead sponsor
Integra LifeSciences Corporation
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2024
Completion date
August 31, 2025
Enrollment
25 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic ulcers, draining wound, necrotizing soft tissue infection, pressure injury, venous ulcer